The anti-tumour effect of a DNA vaccine carrying a fusion gene of human VEGFR2 and IL-12

Because of tumour dependence on angiogenesis, anti-angiogenic therapy has become the most attractive area of basic and clinical study in the field of cancer research. In order to create a synergistic effect on angiogenesis and immune regulation, we designed and constructed a new type of DNA vaccine...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Sha Wen, Jia Zhang, Ping Zhou, Cheng Luo, Yingfu Liu, Zhongwei Xu, Xiaoyi Chen, Houxun Ma
Materialtyp: Artigo
Språk:Inglês
Publicerad: Taylor & Francis Group 2016-09-01
Serie:Biotechnology & Biotechnological Equipment
Ämnen:
VEGFR2
IL-12
tumour
DNA vaccine
Länkar:http://dx.doi.org/10.1080/13102818.2016.1207488
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk